OZZZER AI NEWS · Unite.AI

Orakl Oncology Raises $34M Series A to Expand AI Cancer Drug Prediction

12 Nov 2026

Orakl Oncology Raises $34M Series A to Expand AI Cancer Drug Prediction

Norrsken VC announced on November 12, 2026 that it co-led Orakl Oncology’s oversubscribed $34 million Series A alongside Singular, bringing the AI drug-development company’s total funding to $50 million.

Join free to read this story

Join for OZZZER previews and reviewed analysis. The full publisher article may require a separate subscription.

Join free to open original ↗